Подписаться
Asher Ameli
Asher Ameli
Sr Data scientist
Подтвержден адрес электронной почты в домене northeastern.edu
Название
Процитировано
Процитировано
Год
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ...
Proceedings of the National Academy of Sciences 118 (19), e2025581118, 2021
4192021
Integration of molecular interactome and targeted interaction analysis to identify a COPD disease network module
A Sharma, M Kitsak, MH Cho, A Ameli, X Zhou, Z Jiang, JD Crapo, ...
Scientific reports 8 (1), 14439, 2018
432018
Mechanical forces induce an asthma gene signature in healthy airway epithelial cells
A Kılıç, A Ameli, JA Park, AT Kho, K Tantisira, M Santolini, F Cheng, ...
Scientific reports 10 (1), 966, 2020
392020
Whole exome sequencing analysis in severe chronic obstructive pulmonary disease
D Qiao, A Ameli, D Prokopenko, H Chen, AT Kho, MM Parker, J Morrow, ...
Human molecular genetics 27 (21), 3801-3812, 2018
382018
Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients
T Mellors, JB Withers, A Ameli, A Jones, M Wang, L Zhang, HN Sanchez, ...
Network and Systems Medicine 3 (1), 91-104, 2020
352020
Network medicine framework for identifying drug repurposing opportunities for COVID-19. ArXiv
DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ...
arXiv preprint arXiv:2004.07229, 2020
162020
Network medicine framework for identifying drug repurposing opportunities for COVID-19. arXiv 2020
DM Gysi, ÍD Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ...
arXiv preprint arXiv:2004.07229, 2004
122004
Network medicine framework for identifying drug repurposing opportunities for covid-19 (2020)
DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ...
arXiv preprint arXiv:2004.07229, 2004
52004
Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier
SD Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ...
US Patent 11,195,595, 2021
32021
Network Medicine Framework for Identifying Drug Repurposing Opportunities
DM Gysi, AL Barábasi, IF Do Valle, O Varol, X Gan, A Ameli, J Loscalzo, ...
US Patent App. 17/456,519, 2022
12022
Methods of treating a subject suffering from rheumatoid arthritis with anti-tnf therapy based in part on a trained machine learning classifier
S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ...
US Patent App. 18/450,222, 2023
2023
Methods of treating a subject suffering from rheumatoid arthritis with alternative to anti-TNF therapy based in part on a trained machine learning classifier
S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ...
US Patent 11,783,913, 2023
2023
Methods of treating a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier
S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ...
US Patent 11,456,056, 2022
2022
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19 (preprint)
DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, SD Ghiassian, ...
2020
Network Medicine Approaches to Diagnostics and Therapeutics
A Ameli
Northeastern University, 2020
2020
Exploiting the structure of temporal networks to identify the keys genes in diseases
A Ameli, Z Jabalameli, M Santolini, A Kho, S Weiss, A Sharma
NetSci, 2017
2017
Predicting protein-protein interactions with latent geometry
M Kitsak, R Aldecoa, I Voitalov, A Ameli, A Sharma, N Johnson, A Dhroso, ...
NetSci, 2017
2017
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–17